Journal
NANOSCALE
Volume 9, Issue 18, Pages 6111-6121Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c7nr00947j
Keywords
-
Categories
Funding
- Agencia de Gestio d'ajuts Universitaris i de Recerca (AGAUR) from the Catalan Government [BE-DGR-2010]
- Instituto Carlos III
- MINECO [FPI BES-2011-044872]
- Spanish Ministry of Science and Innovation [BIO2013-44973-R]
- ICREA Funding Source: Custom
Ask authors/readers for more resources
Gold nanoparticles (17 nm) have been functionalized with the antiangiogenic monoclonal antibody drug Cetuximab at a well-defined orientation and coverage density of antibodies. Functionalization has been carried out through site-directed chemistry via the selective oxidation of the carbohydrate moiety of antibodies linked to a thiolated hydrazide. A431 tumor cells have been exposed to these conjugates for in vitro evaluation of their effects. In addition to epithelial growth factor receptor blocking, trafficking and signaling alterations were also observed. Thus, the blocking effects of Cetuximab were increased and sustained for a longer time when associated with the nanoparticles. Enhancing antibody therapy effects by decreasing the needed dose and prolonging its effect by avoiding receptor recycling may serve to obtain increased therapeutic benefits for immunotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available